Tenon Medical is trading 10.13% higher at $4.45, with no direct cause established for the pre-market rise. - No new company-specific announcement dated October 2 was found to explain the move. - The September 30 announcement of the full commercial launch of its SImmetry+ system followed an alpha launch that generated approximately $1.2 million in incremental revenue; this news predates the move. - The broader market is firmer, while the supplied healthcare-sector context is negative; neither clearly explains the gain.